Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,158.00
Bid: 1,146.00
Ask: 1,148.00
Change: 22.00 (1.94%)
Spread: 2.00 (0.175%)
Open: 1,140.00
High: 1,158.00
Low: 1,120.00
Prev. Close: 1,136.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

20 Feb 2023 15:44

RNS Number : 4857Q
Georgia Capital PLC
20 February 2023
 

London, 20 February 2023

 

 

 

Georgia Capital announces market purchase of shares for its Executive Equity Compensation Trust

 

Georgia Capital PLC (CGEO or the Group) was notified by Sanne Fiduciary Services Limited (Sanne), acting as trustee of the JSC Georgia Capital Executive Equity Compensation Trust (the Trust), that Sanne, through an independent broker, purchased in the market 65,000 CGEO ordinary shares with a nominal value of £0.01 each (Shares) at a price of £7.74 (rounded to two decimal points) per Share, traded on 17 February 2023 with a settlement date of 21 February 2023.

 

The Trust holds the Shares for the purpose of satisfying awards to be awarded to beneficiaries of the Trust. The executive directors and persons discharging managerial responsibility of the Group are potential beneficiaries under the Trust and are therefore treated as having an interest in such Shares. Upon settlement of the above transaction, the Trust will hold a total of 3,994,377 Shares, representing approximately 8.91% of CGEO's issued ordinary share capital.

 

Of the 3,994,377 Shares held by the Trust, 1,715,912 are allocated to existing awards.

 

 

Name of authorised official of issuer responsible for making notification: Link Company Matters Limited, Company Secretary

 

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a clinics and diagnostics business, (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20.0% equity stake in the water utility business and a 20.6% equity stake (at 31-Dec-22) in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge

 


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEBLFLXLLZBBF
Date   Source Headline
26th Apr 20233:44 pmRNSTransaction in Own Shares
25th Apr 20235:32 pmRNSTransaction in Own Shares
24th Apr 20234:21 pmRNSTransaction in Own Shares
24th Apr 20233:34 pmRNSDirector/PDMR Shareholding
20th Apr 20235:34 pmRNSTransaction in Own Shares
19th Apr 20235:33 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
14th Apr 20232:56 pmRNSHolding(s) in Company
14th Apr 202311:51 amRNSDirector/PDMR Shareholding
13th Apr 20235:39 pmRNSTransaction in Own Shares
13th Apr 20238:00 amRNSNotice of AGM
13th Apr 20237:00 amRNSTransfer to a Standard Listing on the LSE
12th Apr 20237:00 amRNSLaunch of US$ 10 million share buyback programme
11th Apr 20235:30 pmRNSGeorgia Capital
11th Apr 202311:20 amRNSDirector/PDMR Shareholding
3rd Apr 202312:50 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSUpdate on divestments from subscale businesses
27th Mar 20235:00 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSAnnual Financial Report
20th Mar 20231:16 pmRNSDirector/PDMR Shareholding
14th Mar 202312:36 pmRNSResult of Meeting
10th Mar 20233:23 pmRNSDirector/PDMR Shareholding
6th Mar 20233:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSEducation business continues to expand
28th Feb 20234:32 pmRNSHolding(s) in Company
27th Feb 20233:04 pmRNSDirector/PDMR Shareholding
20th Feb 20233:44 pmRNSDirector/PDMR Shareholding
20th Feb 20237:00 amRNSFinal Results
17th Feb 202310:33 amRNSNotice of GM
14th Feb 202311:00 amRNSNotice of Results
13th Feb 20234:15 pmRNSDirector/PDMR Shareholding
6th Feb 20233:37 pmRNSDirector/PDMR Shareholding
30th Jan 20235:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20235:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20234:59 pmRNSDirector/PDMR Shareholding
20th Jan 20235:33 pmRNSHolding(s) in Company
19th Jan 202311:58 amRNSDirector/PDMR Shareholding
16th Jan 20235:55 pmRNSDirector/PDMR Shareholding
13th Jan 20235:04 pmRNSDirector/PDMR Shareholding
6th Jan 20235:34 pmRNSDirector/PDMR Shareholding
29th Dec 20224:29 pmRNSDirector/PDMR Shareholding
28th Dec 20229:27 amRNSDirector/PDMR Shareholding
20th Dec 202212:57 pmRNSChanges to the Board Committees
19th Dec 20221:01 pmRNSDirector/PDMR Shareholding
19th Dec 202212:58 pmRNSHolding(s) in Company
12th Dec 20221:33 pmRNSDirector/PDMR Shareholding
9th Dec 20224:13 pmRNSHolding(s) in Company
8th Dec 20224:08 pmRNSHolding(s) in Company
8th Dec 20224:05 pmRNSHolding(s) in Company
8th Dec 20224:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.